Skip to main content
Clinical Trials/NCT00852878
NCT00852878
Withdrawn
Not Applicable

The Treatment of Recurrent Abdominal Pain in Children: A Comparison of Biofeedback and Behavioral Intervention

Kaiser Permanente1 site in 1 countryMarch 2009

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Recurrent Abdominal Pain
Sponsor
Kaiser Permanente
Locations
1
Primary Endpoint
The measurable primary outcome will use equivalency testing on changes in pain diary ratings, using the average weekly pain intensity and frequency as recorded in the pain dairy
Status
Withdrawn
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to determine if two treatments, a biofeedback and behavioral protocol, for recurrent abdominal pain are equally effective.

Detailed Description

Recurrent abdominal pain (RAP) is a functional disorder that affects approximately 10 to 25% of children in the United States. This population tends to be heavy medical users in a search of a treatment for the chronic pain, but at this time there is no standard treatment protocol. The literature proposes that there are two effective treatments for RAP, a relaxation protocol by Sanders et al. (1994) and a biofeedback protocol currently in use at Kaiser, but neither treatment has been widely accepted as standard treatment. A purpose of this study is to gather more data on both treatments to help move one or both treatments into the standard of care for RAP. The hypothesis of this study is that the biofeedback and the relaxation protocols will have equivalent treatment outcomes.

Registry
clinicaltrials.gov
Start Date
March 2009
End Date
January 2010
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • who speak English
  • diagnosis with Recurrent abdominal pain

Exclusion Criteria

  • lactose intolerance, urinary tract infections, or recent head trauma;
  • the use of prescribed or over he counter medications, which may interfere with the biofeedback data;
  • currently receiving other treatment for recurrent abdominal pain;
  • the receipt of a recent and related surgical procedure;
  • children who met criteria for depression or anxiety disorder

Outcomes

Primary Outcomes

The measurable primary outcome will use equivalency testing on changes in pain diary ratings, using the average weekly pain intensity and frequency as recorded in the pain dairy

Time Frame: 3 Months

Secondary Outcomes

  • A measurable secondary outcome will be changes in heart rate variability(3 Months)

Study Sites (1)

Loading locations...

Similar Trials